Xtacy Therapeutics SG&A Expense (Quarterly) Trends

Xtacy Therapeutics Corp (XTCY.CX)

0.025 -0.02 (-44.44%) CAD | CNSX | May 06, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	0.2508M
September 30, 2023	0.1127M
June 30, 2023	0.3701M
March 31, 2023	0.2375M
December 31, 2022	0.1364M
September 30, 2022	0.2377M
June 30, 2022	0.6962M
March 31, 2022	0.1117M
December 31, 2021	0.196M
September 30, 2021	2.642M
June 30, 2021	0.7179M
March 31, 2021	0.2329M
December 31, 2020	0.161M
September 30, 2020	0.3953M
June 30, 2020	0.1928M
March 31, 2020	0.036M
December 31, 2019	0.0492M
September 30, 2019	0.3297M
June 30, 2019	0.8739M
March 31, 2019	0.3176M
December 31, 2018	1.104M
September 30, 2018	3.188M
June 30, 2018	0.0005M
March 31, 2018	0.0169M
December 31, 2017	0.0626M

Date	Value
September 30, 2017	0.066M
June 30, 2017	0.0228M
March 31, 2017	0.0046M
December 31, 2016	0.0649M
September 30, 2016	0.0273M
June 30, 2016	0.0157M
March 31, 2016	0.0587M
December 31, 2015	0.013M
September 30, 2015	0.0235M
June 30, 2015	0.0201M
March 31, 2015	0.0205M
December 31, 2014	0.015M
September 30, 2014	0.0212M
June 30, 2014	0.0287M
March 31, 2014	0.0103M
December 31, 2013	0.0065M
September 30, 2013	0.0237M
June 30, 2013	0.0187M
March 31, 2013	0.0093M
December 31, 2012	0.0147M
September 30, 2012	0.0812M
June 30, 2012	0.0132M
March 31, 2012	0.014M
December 31, 2011	0.0169M
September 30, 2011	0.041M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.036M

Minimum

Mar 2020

2.642M

Maximum

Sep 2021

0.42M

Average

0.2375M

Median

Mar 2023

SG&A Expense (Quarterly) Benchmarks